H.-J. Rupprecht

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

David‐Alexandre Trégouët, Renate B. Schnabel, Marie‐Christine Alessi et al. · Journal of Thrombosis and Haemostasis · 2008 · 81 citations

Thrombosis, Atherogene Study, Cardiovascular Disease +13

Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study

Jan‐Malte Sinning, Christoph Bickel, Claudia‐Martina Messow et al. · European Heart Journal · 2006 · 76 citations

Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI Trial)

H.-J. Rupprecht, Christian W. Hamm, Thomas Ischinger et al. · European Heart Journal · 1996 · 50 citations · Full text

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)

M Bertrand, H.-J. Rupprecht, Philip Urban · ACC Current Journal Review · 2001 · 47 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12

Transthoracic three-dimensional echocardiographic volumetry of distorted left ventricles using rotational scanning

Iri Kupferwasser, S MOHRKAHALY, Peter Stähr et al. · Journal of the American Society of Echocardiography · 1997 · 38 citations

Health Sciences, Medical Imaging, Cardiac Mechanic +7